Neuberger Berman Group’s Faeth Therapeutics FTH Stock Holding History
Bought
Maintained
Sold
Other funds holding FTH
BBA
Neuberger Berman Group's FTH Position: Q3 2026 in Review
Neuberger Berman Group opened a new position in Faeth Therapeutics (FTH) in Q3 2026: 8,000 shares worth $238K. The stake represents ﹤0.01% of the portfolio and ranks #2091 among its holdings.
78 funds tracked by Wall St. Rank hold FTH as of Q3 2026.
- Neuberger Berman Group held 8,000 shares of Faeth Therapeutics worth $238K as of Q3 2026.
- Faeth Therapeutics was a new Neuberger Berman Group position in Q3 2026.
- Faeth Therapeutics made up ﹤0.01% of Neuberger Berman Group's portfolio in Q3 2026, its #2091 holding.
- 78 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q3 2026.
Based on Neuberger Berman Group's 13F filing for Q3 2026, filed 13 Nov 2026.